Literature DB >> 21255645

Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.

Sara Terryn1, Anh Ho, Renaud Beauwens, Olivier Devuyst.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent inherited nephropathy. The development and enlargement of cysts in ADPKD requires tubular cell proliferation, abnormalities in the extracellular matrix and transepithelial fluid secretion. Multiple studies have suggested that fluid secretion across ADPKD cyst-lining cells is driven by the transepithelial secretion of chloride, mediated by the apical CFTR channel and specific basolateral transporters. The whole secretory process is stimulated by increased levels of cAMP in the cells, probably reflecting modifications in the intracellular calcium homeostasis and abnormal stimulation of the vasopressin V2 receptor. This review will focus on the pathophysiology of fluid secretion in ADPKD cysts, starting with classic, morphological and physiological studies that were followed by investigations of the molecular mechanisms involved and therapeutic trials targeting these pathways in cellular and animal models and ADPKD patients. This article is part of a Special Issue entitled: Polycystic Kidney Disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255645     DOI: 10.1016/j.bbadis.2011.01.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

3.  Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics?

Authors:  Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2017-02-13       Impact factor: 3.714

4.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 5.  Cross talk between the Crumbs complex and Hippo signaling in renal epithelial cells.

Authors:  U Michgehl; H Pavenstädt; B Vollenbröker
Journal:  Pflugers Arch       Date:  2017-06-13       Impact factor: 3.657

Review 6.  Apicobasal polarity in the kidney.

Authors:  Marc A Schlüter; Ben Margolis
Journal:  Exp Cell Res       Date:  2012-03-06       Impact factor: 3.905

Review 7.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 8.  Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again.

Authors:  Markus M Rinschen; Bernhard Schermer; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

9.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

10.  P2Y2R is a direct target of HIF-1α and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells.

Authors:  Andre Kraus; Steffen Grampp; Margarete Goppelt-Struebe; Rainer Schreiber; Karl Kunzelmann; Dorien J M Peters; Jens Leipziger; Gunnar Schley; Johannes Schödel; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  Purinergic Signal       Date:  2016-08-26       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.